Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Phase II Study in Japan to Assess the Efficacy and Safety of Aflibercept Administered Every Two Weeks in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Who Progressed During or Following an Oxaliplatin-Based Regimen

NCT01882868 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01882868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01882868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Phase II Study in Japan to Assess the Efficacy and Safety of Aflibercept Administered Every Two Weeks in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Who Progressed During or Following an Oxaliplatin-Based Regimen
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2015
Enrollment
62 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic